+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Diagnostics Market Analysis Report By Technology (Immunohistochemistry, In Situ Hybridization, Digital & Anatomic Pathology), By Application, By End Use, And Segment Forecasts, 2019 - 2025

  • ID: 4751821
  • Report
  • 138 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio SB
  • bioMérieux SA
  • DiaGenic
  • GE Healthcare
  • QIAGEN
  • MORE
The global tissue diagnostics market size is expected to reach USD 6.03 billion by 2025 at a 6.6% CAGR during the forecast period. Major developments pertaining to consolidation, automation, and efficiency analysis to streamline tissue-based disease screening protocols and cash flows have driven this market. Furthermore, collaborations for development of companion diagnostics are anticipated to impact adoption rate of technologies that are employed in the tissue diagnostics arena.

Need for robust diagnostic solutions as a consequence of rising cancer burden has pronounced demand for research initiatives and simultaneous product launches, thus driving the market. For example, in March 2017, California-based OptraScan began offering a subscription-based digital pathology service for research purposes, mainly for smaller labs that are unable to pay for high-end scanners.

In addition, implementation of sequencing technology in tissue-based tests would significantly impact the progress rate of this market. Major leaders like Roche are offering sequencing-based tissue diagnostics products, thus aiding market growth.

Further key findings from the report suggest:
  • By technology, immunohistochemistry (IHC) dominated the market in terms of revenue owing to its widespread usage across laboratories for examining tissues for early disease diagnosis and prediction of therapy response in cancer patients
  • Digital pathology and workflow is expected to grow at the fastest rate owing to rising investment in infrastructure and onsite server for digitizing images. Furthermore, shortage of pathologists has spurred automation in disease testing, thereby driving the segment
  • High incidence of breast cancer, coupled with presence of several products specifically designed for detection of this type of cancer, has resulted in breast cancer accounting for the largest share by application. Advancements in genomics for comprehensive understanding of the genetic markup of a tumor are also anticipated to contribute to segment growth
  • By end use, hospitals have led the overall market owing to high hospitalization rate and subsequent adoption of these assays
  • North America captured a major revenue share owing to presence of a well-established regulatory framework for diagnostics. Furthermore, growing collaboration between diagnostic and pharmaceutical companies in U.S. is driving the regional market
  • F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers, and QIAGEN are some of the key participants in the market. These companies have been investing significantly in novel product development and acquisition of small payers in order to maintain their revenue share.


Please Note: This report will be delivered within 48 hours of ordering.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio SB
  • bioMérieux SA
  • DiaGenic
  • GE Healthcare
  • QIAGEN
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased Database
2.1.2 Internal database
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity Flow & Bottom Up Approach
2.4.2 Approach 2: Top Down and Parent Market Analysis

Chapter 3 Tissue Diagnostics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Worldwide increase in cancer prevalence
3.1.1.2 Advancements in imaging techniques and increasing affordability of diagnostics
3.1.1.3 Growth of personalized therapeutics and diagnostics
3.1.2 Market restraint analysis
3.1.2.1 The high costs associated with R & D and clinical trials
3.1.2.2 Presence of non-value based reimbursement policy
3.2 Penetration & Growth Prospect Mapping For Applications, 2018
3.3 Tissue Diagnostics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s

Chapter 4 Tissue Diagnostics Market Categorization: Technology Estimates & Trend Analysis
4.1 Global Tissue Diagnostics Market: Technology Movement Analysis
4.2 Immunohistochemistry
4.2.1 Global immunohistochemistry for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.2 Instruments
4.2.2.1 Instruments for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.2.2 Slide Staining Systems
4.2.2.2.1 Slide staining systems for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.2.3 Tissue Microarrays
4.2.2.3.1 Tissue microarrays for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.2.4 Tissue Processing Systems
4.2.2.4.1 Tissue processing systems for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.2.5 Slide Scanners
4.2.2.5.1 Slide scanners for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.2.6 Other products
4.2.2.6.1 Other products for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.3 Consumables
4.2.3.1 Consumables for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.3.2 Reagents
4.2.3.2.1 Reagents for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.3.3 Antibodies
4.2.3.3.1 Antibodies for tissue diagnostics market, 2014 - 2025 (USD Million)
4.2.3.4 Kits
4.2.3.4.1 Kits for tissue diagnostics market, 2014 - 2025 (USD Million)
4.3 In-situ Hybridization
4.3.1 Tissue diagnostics market, 2014 - 2025 (USD Million)
4.3.2 Instruments
4.3.2.1 Instruments for tissue diagnostics market, 2014 - 2025 (USD Million)
4.3.3 Consumables
4.3.3.1 Consumables for tissue diagnostics market, 2014 - 2025 (USD Million)
4.3.4 Software
4.3.4.1 Software for tissue diagnostics market, 2014 - 2025 (USD Million)
4.4 Primary & Special Staining
4.4.1 Tissue diagnostics market, 2014 - 2025 (USD Million)
4.5 Digital Pathology & Workflow
4.5.1 Tissue diagnostics market, 2014 - 2025 (USD Million)
4.5.2 Whole slide imaging
4.5.2.1 Imaging for tissue diagnostics market, 2014 - 2025 (USD Million)
4.5.3 Image analysis informatics
4.5.3.1 Image analysis informatics for tissue diagnostics market, 2014 - 2025 (USD Million)
4.5.4 Information management system storage & communication
4.5.4.1 Tissue diagnostics market, 2014 - 2025 (USD Million)
4.6 Anatomic Pathology
4.6.1 Tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.2 Instruments
4.6.2.1 Instruments for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.2.2 Microtomes & cryostat
4.6.2.2.1 Microtomes & cryostat for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.2.3 Tissue processors
4.6.2.3.1 Tissue processors for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.2.4 Automatic strainers
4.6.2.4.1 Automatic strainers for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.2.5 Other products
4.6.2.5.1 Instruments for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.3 Consumables
4.6.3.1 Consumables for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.3.2 Reagents & antibodies
4.6.3.2.1 Reagents & antibodies for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.3.3 Kits & probes
4.6.3.3.1 Kits & probes for tissue diagnostics market, 2014 - 2025 (USD Million)
4.6.3.4 Others
4.6.3.4.1 Consumables for tissue diagnostics market, 2014 - 2025 (USD Million)

Chapter 5 Tissue Diagnostics Market Categorization: Application Estimates & Trend Analysis
5.1 Global Tissue Diagnostics Market: Application Movement Analysis
5.2 Breast Cancer
5.2.1 Global tissue-based breast cancer diagnostics market, 2014 - 2025 (USD Million)
5.3 Non Small Cell Lung Cancer (NSCLC)
5.3.1 Global tissue-based NSCLC diagnostics market, 2014 - 2025 (USD Million)
5.4 Prostate Cancer
5.4.1 Global tissue-based prostate cancer diagnostics market, 2014 - 2025 (USD Million)
5.5 Gastric Cancer
5.5.1 Global tissue-based gastric cancer diagnostics market, 2014 - 2025 (USD Million)
5.6 Other Cancers
5.6.1 Global tissue-based other cancer diagnostics market, 2014 - 2025 (USD Million)

Chapter 6 Tissue Diagnostics Market Categorization: End-use Category Estimates & Trend Analysis
6.1 Global Tissue Diagnostics Market: End-use Category Movement Analysis
6.2 Hospitals
6.2.1 Global hospital-based tissue diagnostics market, 2014 - 2025 (USD Million)
6.3 Research Laboratories
6.3.1 Global research laboratories market, 2014 - 2025 (USD Million)
6.4 Pharmaceutical Organizations
6.4.1 Global pharmaceutical organizations market, 2014 - 2025 (USD Million)
6.5 Contract Research Organizations (CROS)
6.5.1 Global CRO-based tissue diagnostics market, 2014 - 2025 (USD Million)

Chapter 7 Tissue Diagnostics Market Categorization: Regional Estimates & Trend Analysis, by, Product, Technology, Application, & End-use
7.1 Tissue Diagnostics Market Share By Region, 2018 & 2025
7.2 North America
7.2.1 North America tissue diagnostics market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.2.2.2 U.S. tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.2.2.3 U.S. tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.2.3.2 Canada tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.2.3.3 Canada tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe tissue diagnostics market, 2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.3.2.2 Germany tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.3.2.3 Germany tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.3.3 France
7.3.3.1 France tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.3.3.2 France tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.3.3.3 France tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.3.4 Spain
7.3.4.1 Spain tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.3.4.2 Spain tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.3.4.3 Spain tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific tissue diagnostics market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.4.2.2 Japan tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.4.2.3 Japan tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.4.3.2 China tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.4.3.3 China tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.4.4 India
7.4.4.1 India tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.4.4.2 India tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.4.4.3 India tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America tissue diagnostics market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.5.2.2 Brazil tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.5.2.3 Brazil tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.5.3.2 Mexico tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.5.3.3 Mexico tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa tissue diagnostics market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa tissue diagnostics market, by technology, 2014 - 2025 (USD Million)
7.6.2.2 South Africa tissue diagnostics market, by application, 2014 - 2025 (USD Million)
7.6.2.3 South Africa tissue diagnostics market, by end-use, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 F. Hoffmann-La Roche Ltd
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 Abbott Laboratories
8.3.2.1 Company Overview
8.3.2.1.1 Alere
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.2.4.1 Strategic initiatives (Alere)
8.3.3 Siemens Healthineers
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Danaher
8.3.4.1 Company Overview
8.3.4.1.1 Beckman Coulter, Inc.
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 bioMérieux SA
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 QIAGEN
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Johnson & Johnson Services, Inc.
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 New product development
8.3.7.4 Strategic initiatives
8.3.8 Becton Dickinson & Company (BD)
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 Merck KGaA
8.3.9.1 Company Overview
8.3.9.1.1 Bio Reliance
8.3.9.1.2 Sigma-Aldrich Co. LLC
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 Thermo Fisher Scientific, Inc.
8.3.10.1 Company Overview
8.3.10.1.1 Life Technologies Corporation
8.3.10.1.2 Affymetrix, Inc.
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.11 Agilent Technologies
8.3.11.1 Company Overview
8.3.11.2 Financial Performance
8.3.11.3 Product Benchmarking
8.3.11.4 Strategic Initiatives
8.3.12 GE Healthcare
8.3.12.1 Company Overview
8.3.12.2 Financial Performance
8.3.12.3 Product Benchmarking
8.3.12.4 Strategic Initiatives
8.3.13 BioGenex
8.3.13.1 Company Overview
8.3.13.2 Financial Performance
8.3.13.3 Product Benchmarking
8.3.13.4 Strategic Initiatives
8.3.14 Cell Signalling Technology, Inc.
8.3.14.1 Company Overview
8.3.14.2 Financial Performance
8.3.14.3 Product Benchmarking
8.3.14.4 Strategic Initiatives
8.3.15 Bio SB
8.3.15.1 Company Overview
8.3.15.2 Financial Performance
8.3.15.3 Product Benchmarking
8.3.15.4 Strategic Initiatives
8.3.16 DiaGenic
8.3.16.1 Company Overview
8.3.16.2 Financial Performance
8.3.16.3 Product Benchmarking
8.3.16.4 Strategic Initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher
  • bioMérieux SA
  • QIAGEN
  • Johnson & Johnson Services, Inc.
  • Becton Dickinson & Company (BD)
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies
  • GE Healthcare
  • BioGenex
  • Cell Signaling Technology, Inc.
  • Bio SB
  • DiaGenic
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4751821
Adroll
adroll